Literature DB >> 9588763

Neurotrophic factors and the maldevelopmental hypothesis of schizophrenic psychoses. Review article.

J Thome1, P Foley, P Riederer.   

Abstract

The maldevelopmental model of schizophrenia postulates pathological alterations in embryonal neurogenesis as the etiopathogenetic basis of schizophrenic psychosis; the neurotrophic factor hypothesis explains these changes as the result of disturbances of processes involving the trophic factors. Neurotransmitter deficits are thereby interpreted as epiphenomena of underlying neurotrophic factor deficacy. The functional systems of the various neurotrophic factors are characterized by complex interaction mechanisms. Both primary genetic alterations, and secondary impairments, induced by exogene noxae, of the receptors and signal transducers associated with neurotrophic factors, as well as of the neurotrophic factors themselves are possible. Preliminary clinical studies indicate that schizophrenic psychoses may be associated with changes in the genetic code of certain neurotrophic factors. Various phenomena typical of the schizophrenic psychoses can be interpreted according to the neurotrophic factor hypothesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9588763     DOI: 10.1007/s007020050040

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  12 in total

1.  A meta-analysis of peripheral blood nerve growth factor levels in patients with schizophrenia.

Authors:  X-Y Qin; H-T Wu; C Cao; Y P Loh; Y Cheng
Journal:  Mol Psychiatry       Date:  2017-01-10       Impact factor: 15.992

Review 2.  Some remarks on etiological aspects of early-onset schizophrenia.

Authors:  C Eggers
Journal:  Eur Child Adolesc Psychiatry       Date:  1999       Impact factor: 4.785

3.  Genome-Wide, Integrative Analysis Implicates Exosome-Derived MicroRNA Dysregulation in Schizophrenia.

Authors:  Yang Du; Yun Yu; Yang Hu; Xiao-Wan Li; Ze-Xu Wei; Rui-Yuan Pan; Xue-Song Li; Guang-En Zheng; Xiao-Yan Qin; Qing-Shan Liu; Yong Cheng
Journal:  Schizophr Bull       Date:  2019-10-24       Impact factor: 9.306

4.  Possible association between nonsynonymous polymorphisms of the anaplastic lymphoma kinase (ALK) gene and schizophrenia in a Japanese population.

Authors:  H Kunugi; R Hashimoto; T Okada; H Hori; T Nakabayashi; A Baba; K Kudo; M Omori; S Takahashi; R Tsukue; K Anami; N Hirabayashi; A Kosuga; M Tatsumi; K Kamijima; T Asada; S Harada; K Arima; O Saitoh
Journal:  J Neural Transm (Vienna)       Date:  2006-04-11       Impact factor: 3.575

5.  Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia.

Authors:  J Wong; T M Hyde; H L Cassano; A Deep-Soboslay; J E Kleinman; C Shannon Weickert
Journal:  Neuroscience       Date:  2010-05-27       Impact factor: 3.590

6.  Changes in gene expression after phencyclidine administration in developing rats: a potential animal model for schizophrenia.

Authors:  F Liu; X Zou; N Sadovova; X Zhang; L Shi; L Guo; F Qian; Z Wen; T A Patterson; J P Hanig; M G Paule; W Slikker; C Wang
Journal:  Int J Dev Neurosci       Date:  2010-08-05       Impact factor: 2.457

Review 7.  [Neurogenesis. Relevance for pathophysiology and pharmacotherapy of psychiatric diseases].

Authors:  J Thome; A J Eisch
Journal:  Nervenarzt       Date:  2005-01       Impact factor: 1.214

Review 8.  Antioxidants as potential therapeutics for neuropsychiatric disorders.

Authors:  Chirayu D Pandya; Kristy R Howell; Anilkumar Pillai
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-11-02       Impact factor: 5.067

9.  Association between the brain-derived neurotrophic factor Val66Met polymorphism and therapeutic response to olanzapine in schizophrenia patients.

Authors:  Matea Nikolac Perkovic; Gordana Nedic Erjavec; Maja Zivkovic; Marina Sagud; Suzana Uzun; Alma Mihaljevic-Peles; Oliver Kozumplik; Dorotea Muck-Seler; Nela Pivac
Journal:  Psychopharmacology (Berl)       Date:  2014-03-05       Impact factor: 4.530

Review 10.  [Synaptic vesicle proteins and psychiatric disorders].

Authors:  S Rapp; J Thome
Journal:  Nervenarzt       Date:  2004-07       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.